Mahamaya Lifesciences Limited, incorporated in 2002, operates in the agrochemical industry with a focus on developing and exporting crop protection products and bioproducts. The company’s core business involves manufacturing pesticide formulations, importing vital technical molecules, and registering them with the Central Insecticides Board before marketing them as value-added products. It caters to both domestic agrochemical manufacturers and multinational corporations, ensuring quality and compliance at every stage. With a diverse product range that includes insecticides, herbicides, and biopesticides, Mahamaya Lifesciences aims to contribute to agricultural sustainability and improved crop productivity. Over the years, the company has built a strong foothold in both Indian and international markets, with active exports to several countries across Asia, Africa, and the Middle East. Its continuous investment in product research, formulation innovation, and global registrations has helped it maintain a competitive position in the agrochemical segment.
Investors can apply for the Mahamaya Lifesciences IPO through their bank’s net banking facility using the ASBA (Application Supported by Blocked Amount) option or via online trading platforms provided by their brokers. To apply, investors must log in to their demat or trading account, select the IPO section, and choose “Mahamaya Lifesciences Limited.” After entering bid details such as the quantity and price within the given range, confirm and submit the application. Once submitted, the bid amount will be blocked in the applicant’s bank account until allotment, after which the shares will be credited to the demat account if allotted.
For more details, visit the Mahamaya Lifesciences IPO page.
Mahamaya Lifesciences IPO Details and Objectives
Details
| Information
|
IPO Date
| November 11, 2025 to November 13, 2025
|
Issue Size
| 61,78,800 shares
(aggregating up to ₹70.44 Cr)
|
Price Band
| ₹108 to ₹114 per share
|
Lot Size
| 1200 shares
|
Listing At
| BSE SME
|
Market Maker
| Mansi Share & Stock Broking Pvt.Ltd.
|
Purpose of the IPO
Purchase of Equipment for existing Formulation plant
Funding capital expenditure towards setting up of a new technical manufacturing plant.
Construction of Warehouse Building and Purchase of Machinery
Funding working capital requirement of the Company
General Corporate purposes
Timeline of Mahamaya Lifesciences IPO
Event
| Date
|
|---|
IPO Open Date
| Tue, Nov 11, 2025
|
IPO Close Date
| Thu, Nov 13, 2025
|
Tentative Allotment
| Fri, Nov 14, 2025
|
Initiation of Refunds
| Mon, Nov 17, 2025
|
Credit of Shares to Demat
| Mon, Nov 17, 2025
|
Tentative Listing Date
| Tue, Nov 18, 2025
|
Cut-off time for UPI mandate confirmation
| 5 PM on Thu, Nov 13, 2025
|
Pricing & Lot Size of Mahamaya Lifesciences IPO
Price Band for the IPO
Minimum Lot Size and Application Details
Application
| Lots
| Shares
| Amount
|
Individual investors (Retail) (Min)
| 2
| 2,400
| ₹2,73,600
|
Individual investors (Retail) (Max)
| 2
| 2,400
| ₹2,73,600
|
S-HNI (Min)
| 3
| 3,600
| ₹4,10,400
|
S-HNI (Max)
| 7
| 8,400
| ₹9,57,600
|
B-HNI (Min)
| 8
| 9,600
| ₹10,94,400
|
Mahamaya Lifesciences IPO Application Process
The Mahamaya Lifesciences IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Step 1: Login to Your Trading Platform
Access your trading account using the broker's app or website.
Step 2: Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Step 3: Select the Open IPO and Click Apply
Locate Mahamaya Lifesciences IPO in the list of available IPOs and click the ‘Apply’ button.
Step 4: Enter the Quantity of Shares You Wish to Apply For
Specify the number of shares (minimum lot size: 1200 shares) within the price band of ₹108 to ₹114 per share.
Step 5: Provide Your UPI ID
Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.
Step 6: Confirm the Application
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Step 7: Complete the Process and Wait for Allotment
Submit the application and monitor the allotment status to check if shares have been allocated to you.
Financial Health and Performance
Key Financial Metrics
Total Assets: Grew from ₹77.88 crore in FY23 to ₹218.87 crore as of June 2025.
Total income: Reached ₹84.04 crore in FY25.
Profit After Tax (PAT): Stood at ₹4.10 crore for June 2025.
Net Worth: Recorded at ₹53.50 crore in FY25.
Reserves and Surplus: Recorded at ₹35.73 crore (June 2025), growing steadily over the years.
EBITDA: Stood at ₹8.04 crore in June 2025.
Recent Performance and Growth Prospects
The company has witnessed consistent growth in its asset base, reflecting expansion in its overall operations and resource capacity.
Its total income has shown a steady upward movement, indicating strong business performance and improved revenue generation.
Profitability has remained stable, supported by efficient cost management and operational effectiveness.
The company’s net worth has strengthened over time, showcasing a healthy financial position and sound capital structure.
Reserves and surplus have continued to grow, reflecting retained earnings and a focus on long-term sustainability.
The company’s operating performance has improved, as seen in its positive earnings before interest, tax, depreciation, and amortisation, highlighting operational efficiency and business resilience.
Investment Risks and Opportunities
Potential Risks of Investing in the IPO
The company operates in the agrochemical sector, which is influenced by environmental regulations, weather conditions, and changing government policies that can affect demand and production cycles.
Dependence on imported raw materials and technical molecules exposes the company to supply chain disruptions, currency fluctuations, and geopolitical risks that may impact cost efficiency.
Opportunities and Growth Potential
Mahamaya Lifesciences has a diversified product portfolio and a growing international presence, positioning it to capitalise on the increasing global demand for sustainable crop protection solutions.
Planned investments from the IPO proceeds, such as setting up a new technical manufacturing plant and expanding warehouse capacity, are expected to enhance production capabilities and strengthen its market reach.
Key Performance Indicator (KPI)
KPI
| Values
|
ROE
| 34.94%
|
ROCE
| 23.15%
|
Debt/Equity
| 1.08
|
RoNW
| 26.19%
|
PAT Margin
| 4.84%
|
EBITDA Margin
| 9.22%
|
Price to Book Value
| 9.40
|
Market Capitalization
| 266.82
|
Mahamaya Lifesciences IPO Registrar & Lead Managers
Registrar
| Lead Manager(s)
|
|---|
Kfin Technologies Ltd.
| Oneview Corporate Advisors Pvt.Ltd.
|
Company Address of Mahamaya Lifesciences Ltd
Mahamaya Lifesciences Ltd. Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1 Delhi, New Delhi, 110020
Phone: +91-1146561474
Email: cs@mahamayalifesciences.com
Website: https://www.mahamayalifesciences.com/
Conclusion
In conclusion, Mahamaya Lifesciences Limited continues to operate as an established participant in the agrochemical sector with activities spanning manufacturing, importing, and exporting of crop protection products. The company’s diversified business model, regulatory focus, and market presence across domestic and international territories outline its operational breadth within the industry.
The IPO proceeds are intended for business expansion, capacity enhancement, and working capital needs, aligning with the company’s ongoing plans to strengthen its manufacturing infrastructure. Investors can review the details and apply through authorised trading platforms or banking channels as per the specified process and schedule.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Mahamaya Lifesciences IPO allotment status.